Member Exclusive

Tumor-targeting drug displays promise for osteosarcoma patients

A study led by The University of Texas MD Anderson Cancer Center (Houston, TX, USA) has found a novel drug that could have the potential as a new therapeutic strategy for osteosarcoma.

Go to the profile of Peter Brown
Jul 27, 2017

Please sign in or register for FREE to view this content

Register to MedChemNet – the medicinal chemistry network

MedChemNet is a communal space where industry and academic professionals can come together to discuss the latest research and developments, share thoughts and opinions, and build valuable international relationships.


No comments yet. Start the conversation...